News on Mendelian diseases, hereditary cancer, variant classification, cystic fibrosis testing and more.
The layoffs occurred across 23andMe's consumer business, which is being restructured, but did not impact its therapeutics business.
The Geisinger National Precision Health Initiative ended in 2019 but its leaders joined Genome Medical to bring genomics-informed care to other health systems.
The deal provides whole-genome sequencing for patients with rare diseases or cancer and could make sequencing part of the standard of care for NHS England.
The new guidelines are meant to assist medical professionals in understanding the complexity and implications of exome sequencing in prenatal care.
Invitae will provide genetic testing for 109 genes associated with the conditions, while BioMarin will provide financial support for the program.
